血管活性药物评分联合乳酸预测VA-ECMO心脏术后患者死亡
本研究回顾性分析222例心脏术后心源性休克需VA-ECMO的成人患者,按VIS 24.3和乳酸6.85 mmol/L分4组。院内死亡率随评分与乳酸升高而增加,联合评估有助于决定VA-ECMO启动时机。
要点
- VIS>24.3且乳酸>6.85 mmol/L与院内死亡独立相关。
- 两指标均未超过阈值时启动VA-ECMO,院内及30天结局更优。
- 联合评估VIS与乳酸可指导VA-ECMO启动决策。
核心结论
- 在需VA-ECMO的心脏术后心源性休克患者中,于VIS未超过24.3且乳酸未超过6.85 mmol/L时启动VA-ECMO与更好的院内及30天结局相关。
主要发现
- 按VIS 24.3和乳酸6.85 mmol/L分4组,院内死亡率分别为37.7%、50.7%、54.8%和76.5%(P<0.001)。
- 4组VA-ECMO成功撤机率分别为73.9%、69%、61.3%和39.2%(P=0.001)。
- 第1组与第4组多器官功能障碍发生率差异有统计学意义(P<0.05)。
- 第1、2、3组累积30天生存率均显著优于第4组(log-rank检验,P<0.05)。
- 逻辑回归显示年龄、VIS>24.3和乳酸>6.85 mmol/L是院内死亡的独立预测因素。
临床怎么用
- 对心脏术后心源性休克考虑VA-ECMO时,应联合评估VIS和乳酸水平。
- 尽量在VIS未超过24.3且乳酸未超过6.85 mmol/L前启动VA-ECMO,以改善预后。
局限性
- 本研究为单中心回顾性分析,结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Our goal was to determine the predictive role of the combined assessment of the vasoactive-inotropic score (VIS) and lactate levels for the prognosis of patients with postcardiotomy cardiogenic shock (PCS) requiring venoarterial extracorporeal membrane oxygenation (VA-ECMO). METHODS: The data of adult patients with PCS requiring VA-ECMO between January 2015 and December 2018 at a tertiary hospital were analysed retrospectively. The incidence of in-hospital mortality and other clinical outcomes was analysed. The associations of the VIS and the lactate concentration and in-hospital mortality were assessed using logistic regression analysis. RESULTS: A total of 222 patients were included and divided into 4 groups according to the cut-off points of the VIS (24.3) and the lactate level (6.85 mmol/L). The in-hospital mortality rates were 37.7%, 50.7%, 54.8% and 76.5% for the 4 groups (P < 0.001), and the rates of successful weaning off VA-ECMO were 73.9%, 69%, 61.3% and 39.2%, respectively (P = 0.001). Groups 1 and 2 exhibited significant differences compared to group 4 in both in-hospital mortality and weaning rates (P < 0.05). There was a statistically significant difference in the incidence of multiple organ dysfunction between group 1 and group 4 (P < 0.05). Groups 1, 2 and 3 demonstrated significantly improved cumulative 30-day survival compared with group 4 (log-rank test, P < 0.05). Logistic regression analysis revealed that age, a VIS > 24.3 and lactate levels > 6.85 mmol/L were independently predictive of in-hospital mortality. CONCLUSIONS: Among patients with PCS requiring VA-ECMO, the initiation before reaching a VIS > 24.3 and lactate levels > 6.85 mmol/L was associated with improved in-hospital and 30-day outcomes, suggesting that the combined assessment of the VIS and lactate levels may be instructive for determining the initiation of VA-ECMO.
引用
- Tian X, Wang L, Li C, et al. Combining the vasoactive-inotropic score with lactate levels to predict mortality in post-cardiotomy patients supported with venoarterial extracorporeal membrane oxygenation. Eur J Cardiothorac Surg. 2024. PMID: 39259189. doi:10.1093/ejcts/ezae334
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。